Biogen: Piper Sandler raises target price to $305 from $245
BIIB•Piper Sandler raised its target price for Biogen to $305 from $245.
Related News
10X Genomics: JPMorgan cuts target price to $65 from $70
TXG•
Vericel Corporation: Truist Securities raises target price to $65 from $52
VCEL•
Gold edges up as softer crude tempers inflation concerns
GLD•
How to stop "securonomics" from killing growth
SPY•
Nvidia crisis may hurt China more than it helps
NVDA•